2013
DOI: 10.5114/wo.2013.35275
|View full text |Cite
|
Sign up to set email alerts
|

Etiology and treatment of osteonecrosis of the mandible

Abstract: Aim of the studyPost-radiogenic osteonecrosis of the mandible is a serious complication in patients with combined treated head/neck tumors. Osteonecrosis of the mandible can also occur following administration of bisphosphonates. In the present article we would like to present our experiences over the last five years in treating both bisphosphonate-associated osteonecrosis and osteoradionecrosis.Material and methodsOf the patients treated in our hospital for bone necrosis of the mandible between January 2005 a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 33 publications
(47 reference statements)
0
3
0
Order By: Relevance
“…It is well known that the removal of necrotic tissue in secondary chronic osteomyelitis of the mandible has a favorable outcome [ 69 ]. However, the outcome of surgical intervention in treatment of patients with primary chronic osteomyelitis of the jaw is uncertain [ 2 , 14 , 20 , 36 , 37 ].…”
Section: Discussionmentioning
confidence: 99%
“…It is well known that the removal of necrotic tissue in secondary chronic osteomyelitis of the mandible has a favorable outcome [ 69 ]. However, the outcome of surgical intervention in treatment of patients with primary chronic osteomyelitis of the jaw is uncertain [ 2 , 14 , 20 , 36 , 37 ].…”
Section: Discussionmentioning
confidence: 99%
“…Osteoradionecrosis (ORN) is a complex metabolic and homeostatic deficiency due to irradiation‐induced tissue injury, which is caused and enhanced by a combination of factors such as the radiation dose, the odontogenic or traumatic procedures, the virulence of microorganisms, the anatomic possibilities for the infection to spread, the immunologic dysfunction, and the systemic diseases (Aitasalo et al, 1998; Bast et al, 2013). To treat early‐stage ORNJ, conservative management such as anti‐inflammation, irrigation, and hyperbaric oxygen therapy (HBO) may be sufficient (Beumer et al, 1984).…”
Section: Introductionmentioning
confidence: 99%
“…Medication-related osteonecrosis of the jaw (MRONJ) is a disabling condition with increasing incidence, a high burden on quality of life, and poor outcomes. Only 50-60% of patients make a full recovery with mucosal healing [1][2][3][4] . Typically, bisphosphonates and denosumab have been associated with this disease, although anti-angiogenic agents have also been reported to cause MRONJ 4,5 .…”
mentioning
confidence: 99%